Hepatitis E should be a global public health priority: recommendations for improving surveillance and prevention

References

• Nelson KE, Labrique AB, Kmush BL. Epidemiology of genotype 1 and 2 Hepatitis E virus infections. Cold Spring Harb Perspect Med. 2019;9(6):a031732
   PubMed Web of Science ®Google Scholar
• Rein DB, Stevens GA, Theaker J, et al. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology. 2012;55(4):988–997
   PubMed Web of Science ®Google Scholar
• World Health Organization. Hepatitis E. cited 2019. [cited 2020 Jul 27]. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-e
   Google Scholar
• IHME Hepatitis Facts: Institute for Health Metrics and Evaluation; [ cited 2019]. Available from:(http://hepatitis.ihme.services/factsheets)
   Google Scholar
• Labrique AB, Sikder SS, Krain LJ, et al. Hepatitis E, a vaccine - preventable cause of maternal deaths. Emerg Infect Dis. 2012;18(9):1401–1404. .
   PubMed Web of Science ®Google Scholar
• Azman AS, Ciglenecki I, Wamala JF, et al., Hepatitis E should be considered a neglected tropical disease. PLoS Negl Trop Dis. 13(7): e0007453. 2019. .
   PubMed Web of Science ®Google Scholar
• Webb GW, Dalton HR. Hepatitis E: an underestimated emerging threat. Ther Adv Infect Dis. 2019;6:1–18.
   Web of Science ®Google Scholar
• Capai L, Charrel R, Falchi A. Hepatitis E in high-income countries: what do we know? And what are the knowledge gaps Viruses. 2018;10(6):285.
   Web of Science ®Google Scholar
• Zhu FC, Zhang J, Zhang XF, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet. 2010;376(9744):895–902. .
   PubMed Web of Science ®Google Scholar
• Lemon SM, Walker CM. Enterically transmitted non-A, non-B hepatitis and the discovery of Hepatitis E virus. Cold Spring Harb Perspect Med. 2019;9(8):a033449.
   PubMed Web of Science ®Google Scholar
• Himmelsbach K, Bender D, Hildt E. Life cycle and morphogenesis of the hepatitis E virus. Emerg Microbes Infect. 2018;7(1):196.
   PubMed Web of Science ®Google Scholar
• Lu L, Li C, Hagedorn CH. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol. 2006;16(1):5–36.
   PubMed Web of Science ®Google Scholar
• Forni D, Cagliani R, Clerici M, et al. Origin and dispersal of Hepatitis E virus. Emerg Microbes Infect. 2018;7(1):11.
   PubMed Web of Science ®Google Scholar
• Nelson KE, Labrique AB, Kmush BL. Epidemiology of Genotype 1 and 2 Hepatitis E Virus Infections Cold Spring Harb Perspect Med. 2019;9(6):a031732.
   PubMed Web of Science ®Google Scholar
• Tripathy AS, Sharma M, Deoshatwar AR, et al. Study of a hepatitis E virus outbreak involving drinking water and sewage contamination in Shimla, India, 2015-2016. Trans R Soc Trop Med Hyg. 2019;113(12):789–796.
   PubMed Web of Science ®Google Scholar
• Sharma S, Kumar A, Kar P, et al. Risk factors for vertical transmission of hepatitis E virus infection. J Viral Hepat. 2017;24(11):1067–1075. .
   PubMed Web of Science ®Google Scholar
• Denner J. Hepatitis E virus (HEV)-The Future. Viruses. 2019;11(3):251.
   Web of Science ®Google Scholar
• Seth A, Sherman KE. Hepatitis E: what We Think We Know. Clin Liver Dis. 2020;15(S1):S37–4419.
   Google Scholar
• Wu C, Wu X, Xia J. Hepatitis E virus infection during pregnancy. Virol J. 2020;17(1):73.
   PubMed Web of Science ®Google Scholar
• Kamar N, Dalton HR, Abravanel F, et al. Hepatitis E virus infection. Clin Microbiol Rev. 2014;27(1):116–138.
   PubMed Web of Science ®Google Scholar
• Krain LJ, Nelson KE, Labrique AB. Host immune status and response to Hepatitis E virus infection. Clin Microbiol Rev. 2014;27(1):139–165.
   PubMed Web of Science ®Google Scholar
• Kmush BL, Yu H, Huang S, et al. Long-term antibody persistence after Hepatitis E virus infection and vaccination in Dongtai, China. Open Forum Infect Dis. 2019;6(4):ofz144. .
   PubMed Web of Science ®Google Scholar
• Expert Committee on Biological Standardization WHO. Human challenge trials for vaccine development: regulatory considerations. 2016.
   Google Scholar
• Al-Sadeq DW, Majdalawieh AF, Mesleh AG, et al. Laboratory challenges in the diagnosis of hepatitis E virus. J Med Microbiol. 2018;67(4):466–480.
   PubMed Web of Science ®Google Scholar
• STANDARDIZATION ECOB. Recommendations to assure the quality, safety and efficacy of 6 recombinant hepatitis E vaccines. World Health Organization, 2018.
   Google Scholar
• Kmush BL, Zaman K, Yunus M, et al. A ten year immunopersistence study of Hepatitis E antibodies in rural Bangladesh. Am J Epidemiol. 2018;187(7):1501–1510.
   Google Scholar
• Kmush BL, Labrique AB, Dalton HR, et al. Two generations of “Gold Standards”: the impact of a decade in Hepatitis E virus testing innovation on population seroprevalence. Am J Trop Med Hyg. 2015;93(4):714–717. .
   PubMed Web of Science ®Google Scholar
• Stanaway JD, Flaxman AD, Naghavi M, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet. 2016;388(10049):1081–1088. .
   PubMed Web of Science ®Google Scholar
• Wilhelm B, Waddell L, Greig J, et al. Systematic review and meta-analysis of the seroprevalence of hepatitis E virus in the general population across non-endemic countries. PLoS One. 2019;14(6):e0216826.
   PubMed Web of Science ®Google Scholar
• Khudyakov Y, Kamili S. Serological diagnostics of hepatitis E virus infection. Virus Res. 2011;161(1):84–92.
   PubMed Web of Science ®Google Scholar
• Hyams C, Mabayoje DA, Copping R, et al. Serological cross reactivity to CMV and EBV causes problems in the diagnosis of acute hepatitis E virus infection. J Med Virol. 2014;86(3):478–483. .
   PubMed Web of Science ®Google Scholar
• Kmush BL, Labrique AB, Dalton HR, et al. Two Generations of “Gold Standards”: the Impact of a Decade in Hepatitis E Virus Testing Innovation on Population Seroprevalence. Am J Trop Med Hyg. 2015;93(4):714–717. .
   PubMed Web of Science ®Google Scholar
• Vollmer T, Knabbe C, Dreier J. Comparison of Real-Time PCR and antigen assays for detection of hepatitis E virus in blood donors. J Clin Microbiol. 2014;52(6):2150–2156.
   PubMed Web of Science ®Google Scholar
• Baylis SA, Blumel J, Mizusawa S, et al. World Health Organization International Standard to harmonize assays for detection of hepatitis E virus RNA. Emerg Infect Dis. 2013;19(5):729–735. .
   PubMed Web of Science ®Google Scholar
• Izopet J, Labrique AB, Basnyat B, et al. Hepatitis E virus seroprevalence in three hyperendemic areas: nepal, Bangladesh and southwest France. J Clin Virol. 2015;70:39–42.
   PubMed Web of Science ®Google Scholar
• Wu X, Chen P, Lin H, et al. Hepatitis E virus: current epidemiology and vaccine. Hum Vaccin Immunother. 2016;12(10):2603–2610.
   PubMed Web of Science ®Google Scholar
• Carratala A, Joost S. Population density and water balance influence the global occurrence of hepatitis E epidemics. Sci Rep. 2019;9(1):10042.
   PubMed Web of Science ®Google Scholar
• Spina A, Lenglet A, Beversluis D, et al. A large outbreak of Hepatitis E virus genotype 1 infection in an urban setting in Chad likely linked to household level transmission factors, 2016-2017. PLoS One. 2017;12(11):e0188240. .
   PubMed Web of Science ®Google Scholar
• Today ON. Hepatitis E: central African Republic outbreak continues, dozens more cases reported 2018 cited. Available from:http://outbreaknewstoday.com.
   Google Scholar
• Namibia: Hepatitis E Leading Cause of Mortality Among Pregnant Women: @allafrica; 2019 . https://allafrica.com/stories/201911271003.html.
   Google Scholar
• Ray K. Hepatitis E outbreak: India among the global hotspots Decan Herald2019. Available From https://www.deccanherald.com/national/hepatitis-e-outbreak-india-among-the-global-hotspots-746742.html.
   Google Scholar
• Teshale EH, Hu DJ. Hepatitis E: epidemiology and prevention. World J Hepatol. 2011;3(12):285–291.
   PubMedGoogle Scholar
• Hakim MS, Wang W, Bramer WM, et al. The global burden of hepatitis E outbreaks: a systematic review. Liver Int. 2017;37(1):19–31. .
   PubMed Web of Science ®Google Scholar
• Number of hepatitis E infections in Namibia nears 7,000 2020 [ updated 2020 Jan 7]. http://www.xinhuanet.com/english/2020-01/07/c_138685904.htm.
   Google Scholar
• Dagnew M, Belachew A, Tiruneh M, et al. Hepatitis E virus infection among pregnant women in Africa: systematic review and meta-analysis. BMC Infect Dis. 2019;19(1):519.
   PubMed Web of Science ®Google Scholar
• Hassan-Kadle MA, Osman MS, Ogurtsov PP. Epidemiology of viral hepatitis in Somalia: systematic review and meta- analysis study. World J Gastroenterol. 2018;24(34):3927–3957.
   PubMed Web of Science ®Google Scholar
• Boon D, Redd AD, Laeyendecker O, et al. Hepatitis E Virus Seroprevalence and Correlates of Anti-HEV IgG Antibodies in the Rakai District, Uganda. J Infect Dis. 2018;217(5):785–789.
   PubMed Web of Science ®Google Scholar
• Hasan G, Assiri A, Marzuuk N, et al. Incidence and characteristics of hepatitis E virus infection in children in Assiut, Upper Egypt. J Int Med Res. 2016;44(5):1115–1122.
   PubMed Web of Science ®Google Scholar
• Capai L, Falchi A, Charrel R. Meta-Analysis of Human IgG anti-HEV Seroprevalence in Industrialized Countries and a Review of Literature. Viruses. 2019;11(1):84.
   Web of Science ®Google Scholar
• Kamar N, Izopet J, Pavio N, et al. Hepatitis E virus infection. Nat Rev Dis Primers. 2017;3:17086.
   PubMed Web of Science ®Google Scholar
• Rivero-Juarez A, Lopez-Lopez P, Frias M, et al. Hepatitis E Infection in HIV-Infected Patients. Front Microbiol. 2019;10:1425.
   PubMed Web of Science ®Google Scholar
• Patra S, Kumar A, Trivedi SS, et al. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med. 2007;147(1):28–33.
   PubMed Web of Science ®Google Scholar
• Berglov A, Hallager S, Weis N. Hepatitis E during pregnancy: maternal and foetal case-fatality rates and adverse outcomes-A systematic review. J Viral Hepat. 2019;26(11):1240–1248.
   PubMed Web of Science ®Google Scholar
• Lagare A, Ibrahim A, Ousmane S, et al. Outbreak of Hepatitis E virus infection in displaced persons camps in diffa region, niger, 2017. Am J Trop Med Hyg. 2018;99(4):1055–1057.
   PubMed Web of Science ®Google Scholar
• Melgaco JG, Gardinali NR, de Mello VDM, et al. Hepatitis E: update on Prevention and Control. Biomed Res Int. 2018;2018:5769201.
   PubMed Web of Science ®Google Scholar
• Kmush BL, Labrique A, Li W, et al. The Association of Cytokines and Micronutrients with Hepatitis E Virus Infection During Pregnancy and the Postpartum Period in Rural Bangladesh. Am J Trop Med Hyg. 2016;94(1):203–211.
   PubMed Web of Science ®Google Scholar
• Krain LJ, Atwell JE, Nelson KE, et al. Fetal and Neonatal Health Consequences of Vertically Transmitted Hepatitis E Virus Infection. Am J Trop Med Hyg. 2014;90(2):365–370.
   PubMed Web of Science ®Google Scholar
• Horvatits T, Wiesch JS, Lütgehetmann M, et al. The Clinical Perspective on Hepatitis E. Viruses. 2019;11(7):617.
   Web of Science ®Google Scholar
• Ronsmans C, Chowdhury ME, Dasgupta SK, et al. Effect of parent’s death on child survival in rural Bangladesh: a cohort study. Lancet. 2010;375(9730):2024–2031.
   PubMed Web of Science ®Google Scholar
• Beegle K, De Weerdt J, Dercon S. The intergenerational impact of the African orphans crisis: a cohort study from an HIV/AIDS affected area. IntJEpidemiol. 2009;38(2):561–568.
   Google Scholar
• Niger: Hepatitis E Outbreak - Apr 2017. @reliefweb 2019.
   Google Scholar
• Namibia defends capital’s water safety amid Hepatitis E outbreak 2020 [ updated 2018 Feb 8]. http://www.xinhuanet.com/english/2018-02/08/c_136957174.htm.
   Google Scholar
• Langlois EV, Haines A, Tomson G, et al. Refugees: towards better access to health-care services. Lancet. 2016;387(10016):319–321.
   PubMed Web of Science ®Google Scholar
• Shrestha A, Gupta BP, Lama TK. Current Treatment of Acute and Chronic Hepatitis E Virus Infection: role of Antivirals. Euroasian J Hepatogastroenterol. 2017;7(1):73–77.
   PubMedGoogle Scholar
• Netzler NE, Enosi Tuipulotu D, Vasudevan SG, et al. Antiviral candidates for treating hepatitis E Virus Infection. Antimicrob Agents Chemother. 2019;63(6):e00003.
   PubMed Web of Science ®Google Scholar
• Lemoine M, Nayagam S, Thursz M. Viral hepatitis in resource-limited countries and access to antiviral therapies: current and future challenges. Future Virol. 2013;8(4):371–380.
   PubMed Web of Science ®Google Scholar
• Fitzsimons D, Hendrickx G, Hallauer J, et al. Innovative sources for funding of viral hepatitis prevention and treatment in low- and middle-income countries: a roundtable meeting report. Hepatol, Med Policy. 2016;1(1):1–10.
   Google Scholar
• Spina A, Beversluis D, Irwin A, et al. Learning from water treatment and hygiene interventions in response to a hepatitis E outbreak in an open setting in Chad. J Water Health. 2018;16(2):223–232.
   PubMed Web of Science ®Google Scholar
• Guthmann JP, Klovstad H, Boccia D, et al. A large outbreak of hepatitis E among a displaced population in Darfur, Sudan, 2004: the role of water treatment methods. Clin Infect Dis. 2006;42(12):1685–1691.
   PubMed Web of Science ®Google Scholar
• Li SW, Zhao Q, Wu T, et al. The development of a recombinant hepatitis E vaccine HEV 239. Hum Vaccin Immunother. 2015;11(4):908–914.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang XF, Huang SJ, et al., Long-term efficacy of a hepatitis E vaccine. N Engl J Med. 372(10): 914–922. 2015. .
   PubMed Web of Science ®Google Scholar
• Nelson KE, Shih JW, Zhang J, et al. Hepatitis e vaccine to prevent morbidity and mortality during epidemics. Open Forum Infect Dis. 2014;1(3):ofu098.
   PubMedGoogle Scholar
• Safety profile of a recombinant hepatitis E vaccine: Extract from report of GACVS meeting of 2014 Jun 11-12. World Health Organization, 2015; 12:18:13.
   Google Scholar
• WHO. Hepatitis E vaccine: WHO position paper, May 2015. Wkly Epidemiol Rec. 2015;90(18):185–200.
   PubMedGoogle Scholar
• Cooper BS, White LJ, Siddiqui R. Reactive and pre-emptive vaccination strategies to control hepatitis E infection in emergency and refugee settings: A modelling study. PLoS Negl Trop Dis. 2018;12(9):e0006807.
   PubMed Web of Science ®Google Scholar
• Namibia to acquire Hepatitis E vaccine from China, 2020. [February 2, 2020]. Available from:http://www.xinhuanet.com/english/2020-02/03/c_138752998.htm.
   Google Scholar
• Innis BL, Lynch JA. Immunization against Hepatitis E. Cold Spring Harb Perspect Med. 2018;8(11):a032573.
   PubMed Web of Science ®Google Scholar
• Wu X, Chen P, Lin H, et al. Dynamics of 8G12 competitive antibody in “prime-boost” vaccination of Hepatitis E vaccine. Hum Vaccin Immunother. 2017;13(6):1–6.
   Web of Science ®Google Scholar
• Faber M, Willrich N, Schemmerer M, et al. Hepatitis E virus seroprevalence, seroincidence and seroreversion in the German adult population. J Viral Hepat. 2018;25(6):752–758.
   PubMed Web of Science ®Google Scholar
• Su YY, Huang SJ, Guo M, et al. Persistence of antibodies acquired by natural hepatitis E virus infection and effects of vaccination. Clin Microbiol Infect. 2017;23(5):336.e1-.e4.
   Web of Science ®Google Scholar
• World Hepatitis Alliance. Our Story: Milestones on our road to elimination 2019 https://www.worldhepatitisalliance.org/about/our-story.
   Google Scholar
• World Hepatitis Alliance. Sustainable Development Goals (SDGs) 2019. https://www.worldhepatitisalliance.org/sustainable-development-goals-sdgs.
   Google Scholar
• World Health Organization. Global health sector strategy on viral hepatitis 2016–2021. 2016.
   Google Scholar
• Waheed Y, Siddiq M, Jamil Z, et al. Hepatitis elimination by 2030: progress and challenges. World J Gastroenterol. 2018;24(44):4959–4961.
   PubMed Web of Science ®Google Scholar
• Gore C, Hicks J, Deelder W. Funding the elimination of viral hepatitis: donors needed. The Lancet Gastroenterol Hepatol. 2017;2(12):843–845.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Combating Hepatitis b and C to reach elimination by 2030. 2016.
   Google Scholar
• Frontieres MS The end of viral hepatitis by 2030 is impossible without tackling hepatitis E 2016 cited Available from: https://www.msf.ch/nos-actualites/articles/end-viral-hepatitis-2030-impossible-without-tackling-hepatitis-e.
   Google Scholar
• @dailystarnews. WHD 2018: @dailystarnews; 2018 [updated 2018-08-05]. https://www.thedailystar.net/health/whd-2018-1615894.
   Google Scholar
• Zaman K, Dudman S, Stene-Johansen K, et al. HEV study protocol: design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh. BMJ Open. 2020;10(1):e033702.
   PubMed Web of Science ®Google Scholar
• Zhang J, Liu CB, Li RC, et al. Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine. Vaccine. 2009;27(12):1869–1874.
   PubMed Web of Science ®Google Scholar
• Purcell RH, Nguyen H, Shapiro M, et al. Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine. Vaccine. 2003;21(19–20):2607–2615.
   PubMed Web of Science ®Google Scholar
• Chen Z, Lin S, Duan J, et al. Immunogenicity and safety of an accelerated hepatitis E vaccination schedule in healthy adults: a randomized, controlled, open-label, phase IV trial. Clin Microbiol Infect. 2019;25(9):1133–1139.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang XF, Zhou C, et al. Protection against hepatitis E virus infection by naturally acquired and vaccine-induced immunity. Clin Microbiol Infect. 2014;20(6):O397–405.
   PubMed Web of Science ®Google Scholar
• Verghese VP, Robinson JL. A systematic review of hepatitis E virus infection in children. Clin Infect Dis. 2014;59(5):689–697.
   PubMed Web of Science ®Google Scholar